Breaking Down the Research
Measuring & Evaluating CHR-p
-
The Comprehensive Assessment of At-Risk Mental States or the CAARMS provides a useful platform to monitor sub-threshold symptoms and determine someone’s risk for a psychosis-spectrum disorder.
-
The Prodromal Questionnaire - Brief (PQ-B) is often used as a self-report screen for prodromal psychosis syndromes. This is generally followed by diagnostic interview in a two-stage evaluation process for youth who are seeking help for these symptoms.
-
The Structured Interview for Psychosis-Risk Syndromes (SIPS) and the Scale of Psychosis-Risk Symptoms (SOPS) are among the most commonly used instruments worldwide for diagnosing and evaluating young people with a clinical high-risk (CHR) syndrome for psychosis. These have been thoroughly researched and show high reliability between interviewers.
Developing a CHR-p Program
-
There have been many studies on the benefits of specialized early intervention for psychosis. These interventions can include integrated therapy, family treatment, and (in some cases) low-dose medication.
-
Reducing the time between a person’s first psychosis symptoms and their entry into treatment, known as the duration of untreated psychosis (DUP), is a major goal of CHR-P treatment. High-quality, early treatment for psychosis is the best way to promote recovery.
-
As more clinics seek to develop their own early intervention CHR-p programs, it is helpful to look to established programs for support! We encourage you to read more about the CEDAR, STAR, and RE-SET teams at their websites above, or reach out to M3P to become a part of our network.